Gatorade Zero, a thirst quencher without sugar or carbs, hit stores around the country this week. It comes in orange, lemon lime, and glacier cherry, and is priced in line with the brand's classic sports drink.
United Technologies Co. (NYSE:UTX) has been given a consensus recommendation of “Buy” by the twenty research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Th
The European Central Bank still has a way to go before inflation is on track toward its goal, so policy will need to remain patient and persistent, Executive Board member Peter Praet said on Monday.
Praet, who presents policy proposals at Governing Council meetings in his role as chief economist, said the ECB is monitoring three criteria as it gauges when it can start withdrawing stimulus.....More>>>
The Florida citrus industry was already in big trouble even before Hurricane Irma started closing in. Now experts are worried that the storm could be the final straw that tips many growers into bankruptcy.
The problem until now has not been storms but a disease, known as citrus greening. It’s spread by an insect, and leaves the fruit green, bitter and unusable. As a result, Florida....More>>>
Gold doesn't trade in a vacuum. Markets are connected. What happens in one often affects others. So if you want to understand what's happening with gold, you need to know what's going on in the markets that affect gold. And while lots of traders focus only on the short term, it's important to have a big-picture view, too. The big picture shows you the long-term....More>>>
Xbiotech (NASDAQ:XBIT) has presented the abstract of its European Phase III trial of Xilonix to treat patients with metastatic colorectal cancer (mCRC) refractory to standard treatment at the ESMO GI (European Society for Medical Oncology) 2016, early July. The abstract has shown a 76% relative increase in clinical response rate (CRR), associated....More>>>
Welcome to the latest issue of the PRO Weekly Digest. Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users, we publish highlights from our PRO coverage as well as feature interviews and other notable goings-on with SA PRO. Comment below or email us at pro-editors at seekingalpha.com to let us know what you think. Find past editions here.
In our last article, we noted that the middle market for privately held businesses in the United States has about 350,000 firms. Of those, only about 20% are “ready for sale.” And, we mentioned that there are consultants who assist business owners prepare their companies for sale. Just to be clear, these are value enhancement consultants as opposed to investment....More>>>
This is the inaugural article within a series on German Dividend Champions. These are great dividend investments in German stocks which are currently undervalued and offer significant upside potential. Compared to US stocks like PG or JNJ even the German heavyweights have less impressive and long-reaching dividend track records. That’s why I regularly will only refer to historic data beginning....More>>>
Make way for some waves. CVS Health (CVS) and Express Scripts (ESRX) have released their formulary exclusion list for 2017, which details which prescription drugs will not be covered by health plans.
Why do we care? Commercial payors have been showing signs of pushing back against high drugs costs, which is a huge concern for drug companies and their investors. The coverage list determines....More>>>
Rival chipmakers Intel (NASDAQ:INTC) and AMD (NASDAQ:AMD) recently set aside their differences to launch Kaby Lake G, a laptop chipset that merges an eighth-generation quad-core Intel CPU with AMD's custom Radeon RX Vega M GPU. Intel claims the chipset can match NVIDIA's (NASDAQ:NVDA) GTX 1050 i
PetIQ Inc (NASDAQ:PETQ) CEO Mccord Christensen sold 13,652 shares of the company’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $23.00, for a total transaction of $313,996.00. The sale was disclosed in a filing with the Securities & Exchange C
TD Ameritrade (NASDAQ: AMTD) and Goldman Sachs Group (NYSE:GS) are both large-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations
Mesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 989 shares of the business’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $191.17, for a total transaction of $189,067.13. Following the transaction, the director now directly ow
Financial Advisory Service Inc. trimmed its position in shares of Facebook, Inc. Common Stock (NASDAQ:FB) by 16.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,563 shares of the social networking company